Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
8
Number of overlapping holdings
7.1%
% of IXJ's 112 holdings also in IHE
21.6%
% of IHE's 38 holdings also in IXJ
Overlap by Weight
Sector Drift (IXJ minus IHE)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in IXJ |
Weight in IHE |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 8.7% | 20.4% | 8.7% |
|
JOHNSON & JOHNSON | 4.7% | 21.2% | 4.7% |
|
MERCK & CO. INC. | 3.6% | 4.2% | 3.6% |
|
PFIZER INC | 2.0% | 4.1% | 2.0% |
|
BRISTOL-MYERS SQUIBB CO | 1.6% | 5.5% | 1.6% |
Position Highlights (Non-Overlapping Exposures)
IXJ Overweight Relative to IHE
|
UNITEDHEALTH GROUP INC | 6.7% |
 |
NOVO NORDISK A/S-B | 4.7% |
|
ABBVIE INC | 4.3% |
 |
ASTRAZENECA PLC | 2.9% |
|
THERMO FISHER SCIENTIFIC INC | 2.8% |
 |
ROCHE HOLDING LTD | 2.8% |
|
ABBOTT LABORATORIES | 2.8% |
|
NOVARTIS AG | 2.7% |
|
INTUITIVE SURGICAL INC | 2.7% |
|
DANAHER CORP | 2.1% |
IXJ Underweight Relative to IHE
|
JOHNSON & JOHNSON | -16.5% |
|
ELI LILLY & CO | -11.7% |
|
VIATRIS, INC. | -5.1% |
|
CATALENT INC | -4.6% |
|
ROYALTY PHARMA PLC CLASS A | -4.0% |
|
BRISTOL-MYERS SQUIBB CO | -3.9% |
|
INTRA-CELLULAR THERAPIES INC | -3.4% |
|
ZOETIS INC | -3.3% |
 |
JAZZ PHARMACEUTICALS PLC | -3.1% |
|
ELANCO ANIMAL HEALTH, INC. | -2.5% |